Rare2030 is led by EURORDIS-Rare Diseases Europe (Project Coordinator) who is tasked with the strategic/scientific coordination of the project. ISINNOVA (Project Manager) is responsible for the administrative and operative management – together representatives from these institutions making up the Management Board. Six additional partners complement the Management Board making up the Executive Management Committee in executing the project’s objectives. A multi-stakeholder Panel of Experts comprised of over 100 thought leaders in the field of rare diseases and health serve as the central consultative body during the Foresight study.